CA
JAZZ icon

Commerzbank Aktiengesellschaft’s Jazz Pharmaceuticals JAZZ Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-3,137
Closed -$455K – 807
2017
Q1 		$455K Sell
3,137
-6,466
-67% -$842K 0.01% 670
2016
Q4 		$1.05M Buy
9,603
+939
+11% +$105K 0.02% 443
2016
Q3 		$1.05M Buy
8,664
+4,370
+102% +$589K 0.02% 423
2016
Q2 		$607K Sell
4,294
-3,126
-42% -$461K ﹤0.01% 605
2016
Q1 		$969K Buy
7,420
+1,152
+18% +$143K 0.01% 505
2015
Q4 		$881K Buy
6,268
+1,945
+45% +$270K 0.01% 698
2015
Q3 		$574K Sell
4,323
-1,039
-19% -$179K ﹤0.01% 725
2015
Q2 		$944K Sell
5,362
-369
-6% -$66.3K 0.01% 829
2015
Q1 		$990K Sell
5,731
-574
-9% -$98.5K 0.01% 792
2014
Q4 		$1.03M Buy
6,305
+4,036
+178% +$670K 0.01% 837
2014
Q3 		$364K Sell
2,269
-61
-3% -$9.38K ﹤0.01% 1014
2014
Q2 		$343K Buy
2,330
+6
+0.3% +$832 ﹤0.01% 1067
2014
Q1 		$322K Sell
2,324
-2,456
-51% -$370K ﹤0.01% 1078
2013
Q4 		$725K Sell
4,780
-228
-5% -$23.6K ﹤0.01% 957
2013
Q3 		$461K Sell
5,008
-1,949
-28% -$157K ﹤0.01% 1001
2013
Q2 		$478K Buy
+6,957
New +$425K ﹤0.01% 1081

Other funds holding JAZZ

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Commerzbank Aktiengesellschaft's JAZZ Position: Q2 2017 in Review

Commerzbank Aktiengesellschaft sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2017, closing a stake of 3,137 shares — an estimated $455K sold.

Commerzbank Aktiengesellschaft first reported a position in JAZZ in Q2 2013 and held it in 16 quarters. The position peaked at $1.05M in Q3 2016. 319 funds tracked by Wall St. Rank hold JAZZ as of Q2 2017.

  • Commerzbank Aktiengesellschaft reported no remaining Jazz Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
  • Commerzbank Aktiengesellschaft sold 3,137 Jazz Pharmaceuticals shares in Q2 2017, an estimated $455K.
  • Commerzbank Aktiengesellschaft first reported a position in Jazz Pharmaceuticals in Q2 2013 and held it in 16 quarters.
  • Commerzbank Aktiengesellschaft's Jazz Pharmaceuticals position peaked at $1.05M in Q3 2016.
  • 319 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2017.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q2 2017, filed 9 Aug 2017.